Table 2.
AUC values of panels for MB and other groups distinction on urine metabolomics.
| The AUC of discovery group | The AUC of validation group | sensitivity | specificity: | |
|---|---|---|---|---|
| MB vs. healthy control(a) | 0.947 | 0.906 | 0.892 | 0.810 |
| MB vs. brain benign diseases (b) | 0.900 | 0.873 | 0.892 | 0.882 |
| MB vs. other malignant tumours (c) | 0.842 | 0.885 | 1 | 0.702 |
| MB vs. non-MB(d) | 0.888 | 0.801 | 0.908 | 0.757 |
(a) panel: Tetrahydrocortisone; Cortolone; N-Acetylasparagine.
(b) panel: Tetrahydrocortisone; Cortolone; 18-carboxy dinor Leukotriene B4.
(c) panel: Tetrahydrocortisone; Cortolone; L-Dopa; 20-Oxo-leukotriene E4.
(d) panel: Tetrahydrocortisone; Cortolone.